WsolA. Cardiovascular safety of psychedelic medicine: Current status and future directions. Pharmacol Rep, 2023; 75(6):1362–1380; doi: 10.1007/s43440-023-00539-4
2.
MujtabaS, RomeroJ, TaubCC. Methadone, QTc prolongation and torsades de pointes: Current concepts, management and a hidden twist in the tale? J Cardiovasc Dis Res, 2013; 4(4):229–235; doi: 10.1016/j.jcdr.2013.10.001
3.
SinghK, JainA, PanchalI, et al.Ondansetron-induced QT prolongation among various age groups: A systematic review and meta-analysis. Egypt Heart J, 2023; 75(1):56; doi: 10.1186/s43044-023-00385-y
4.
SoghomonyanS, StoiceaN, AckermannW, et al.PONV management in patients with QTc prolongation on the EKG. Front Pharmacol, 2020; 11:565704; doi: 10.3389/fphar.2020.565704
5.
GattusoJJ, PerkinsD, RuffellS, et al.Default mode network modulation by psychedelics: A systematic review. Int J Neuropsychopharmacol, 2023; 26(3):155–188; doi: 10.1093/ijnp/pyac074